Key Studies and Articles
As I come across them I will edit this post and list important references to have them in one location.
Blagosklonny Article on Rapalogs
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482593/
Dasatanib Quercitin study
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(19)30591-2/fulltext
Senolytic comparison
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197652/#!po=39.3617
Mayo clinic Fisetin study
https://clinicaltrials.gov/ct2/show/NCT03430037?cond=fisetin&cntry=US&draw=1&rank=2
-
Referring to the Dasatinib and Quercetin study, does anyone know why they gave a single 100 mg daily dose of D and split the daily Q dosage into two 500 mg doses?
"a single 3-day course of oral D + Q (D: 100 mg/day, Q: 500 mg twice daily"
-
-
Karl She says only one study has been done using D&Q In humans. She missed this one: Short-Term Simultaneous D&Q Improves Physical Capacity in Humans
-
Larry Thanks finding that study. She also states on website that Quercetin is the ONLY otc senolytic which is wrong - Fisetin, Curcumin and others.
-
-
Interesting differentiation between senostatics like metformin and rapamycin and senolytics like dasatinab